Project Number 1R01AG063826-01 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator BRINTON, ROBERTA EILEEN Principal Investigator First Name ROBERTA Principal Investigator Last Name BRINTON Awardee Organization UNIVERSITY OF ARIZONA Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $8,410,912 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
